Scfv Antibody | List of Frontiers open access articles

Original Research

Published on 07 Mar 2018

Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay

in Microbial Immunology

Hang Yang
Yanfang Zhong
Juncheng Wang
Qinghong Zhang
Xiulan Li
Sumei Ling
Shihua Wang
Rongzhi Wang

Frontiers in Microbiology

doi 10.3389/fmicb.2018.00261

12,396 views
23 citations

Original Research

Published on 12 Oct 2022

Isolation of SARS-CoV-2-blocking recombinant antibody fragments and characterisation of their binding to variant spike proteins

in Biomedical Nanotechnology

Delphine Antoine
Moein Mohammadi
Chloe E. McDermott
Eithne Walsh
Patrick A. Johnson
Karen E. Wawrousek
J. Gerard Wall

Frontiers in Nanotechnology

doi 10.3389/fnano.2022.1028186

3,217 views
2 citations

Original Research

Published on 06 Nov 2013

Engineering production of functional scFv antibody in E. coli by co-expressing the molecule chaperone Skp

in Molecular Bacterial Pathogenesis

Rongzhi Wang
Shuangshuang Xiang
Youjun Feng
Swaminath Srinivas
Yonghui Zhang
Mingshen Lin
Shihua Wang

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2013.00072

34,815 views
57 citations

Original Research

Published on 24 Mar 2022

Targeted Codelivery of Prodigiosin and Simvastatin Using Smart BioMOF: Functionalization by Recombinant Anti-VEGFR1 scFv

in Nanobiotechnology

Somayyeh Mirzaeinia
Sedighe Zeinali
Nediljko Budisa
Hamid Reza Karbalaei-Heidari

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2022.866275

4,483 views
11 citations

Original Research

Published on 18 Dec 2020

Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity

in Cancer Molecular Targets and Therapeutics

Guang-Quan Liang
Jing Liu
Xiao-Xin Zhou
Ze-Xiong Lin
Tao Chen
Guo Chen
Henry Wei

Frontiers in Oncology

doi 10.3389/fonc.2020.571194

5,352 views
7 citations

Hypothesis and Theory

Published on 18 May 2017

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity

in Alloimmunity and Transplantation

Congcong Zhang
Pranav Oberoi
Sarah Oelsner
Anja Waldmann
Aline Lindner
Torsten Tonn
Winfried S. Wels

Frontiers in Immunology

doi 10.3389/fimmu.2017.00533

48,463 views
289 citations

Review

Published on 31 May 2022

Sensing Soluble Immune Checkpoint Molecules and Disease-Relevant Cytokines in Cancer: A Novel Paradigm in Disease Diagnosis and Monitoring

in Biosensors

Nidhi Pandey
Debarati Biswas
Nirmita Dutta
Anita Hansda
Gorachand Dutta
Gayatri Mukherjee

Frontiers in Sensors

doi 10.3389/fsens.2022.789771

4,090 views
10 citations

Articles

Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay

Isolation of SARS-CoV-2-blocking recombinant antibody fragments and characterisation of their binding to variant spike proteins

Engineering production of functional scFv antibody in E. coli by co-expressing the molecule chaperone Skp

Targeted Codelivery of Prodigiosin and Simvastatin Using Smart BioMOF: Functionalization by Recombinant Anti-VEGFR1 scFv

Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity

Sensing Soluble Immune Checkpoint Molecules and Disease-Relevant Cytokines in Cancer: A Novel Paradigm in Disease Diagnosis and Monitoring